ENVB
Enveric Biosciences, Inc.5.24
-0.12-2.24%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
5.36MP/E (TTM)
0.00Basic EPS (TTM)
1390.68Dividend Yield
0%Recent Filings
8-K
Registers $1.3M more ATM shares
8-K
$1.5M direct offering closed
Enveric Biosciences closed a $1.5M registered direct offering on January 28, 2026, selling 328,802 shares at $4.41 each to institutional investors, paired with Series G and H warrants for another 328,802 shares each at $4.16 strike. Net proceeds of ~$1.25M target product development and working capital. Warrants cap ownership at 4.99%; no further equity for 15 days. Small cash infusion sustains biotech runway.
8-K
Q1 2026 investor presentation out
Enveric Biosciences released its Q1 2026 Investor Presentation on January 9, 2026, under Regulation FD, furnishing it as Exhibit 99.1 for investor use. Management plans to deploy it, with possible tweaks, in outreach to investors, analysts, and partners. Presentation available on company's site. Not filed under Exchange Act.
8-K
Warrant inducement yields $3.1M
Enveric Biosciences induced holders to exercise 426,390 existing warrants at a reduced $7.05/share, netting ~$3.1M gross proceeds before fees. Closing hit December 12, 2025; company issued new Series E (5-year) and F (18-month) warrants for same shares at $7.05/share. Funds target product development and working capital. New warrants dilute on exercise.
8-K
Stockholders approve dilution measures
Enveric Biosciences stockholders approved three key proposals at the December 11, 2025 Special Meeting with 40.23% turnout. They authorized warrant share issuances exceeding 20% of outstanding stock, a discretionary 1-for-5 to 1-for-15 reverse stock split, and boosting authorized common shares from 100M to 5B. Shareholders decide Nasdaq compliance. Yet dilution looms large.
AIBT
Aibotics Inc.
0.00+0.00
CBIO
Crescent Biopharma, Inc.
12.92-0.29
CNBX
CNBX Pharmaceuticals Inc.
0.00+0.00
CPMV
Mosaic ImmunoEngineering Inc.
0.40+0.00
CYBN
Cybin Inc.
6.66+0.00
DRUG
Bright Minds Biosciences Inc.
93.99+8.32
ELVN
Enliven Therapeutics, Inc.
16.91-0.26
ENDV
Endonovo Therapeutics, Inc.
0.00+0.00
LBRX
LB Pharmaceuticals Inc
19.82-0.04
PBM
Psyence Biomedical Ltd.
1.53+0.05